How lupus is diagnosed: the ANA test, the criteria and what a positive ANA means

Short answer

There is no single lupus test. Diagnosis starts with an ANA blood test: almost everyone with lupus is ANA-positive, but so are many healthy people. A rheumatologist then adds anti-dsDNA, anti-Sm, complement C3 and C4, blood counts and urine tests to your symptoms and exam, and weighs the whole picture against the 2019 ACR/EULAR criteria.

If you have been told your ANA is positive and nobody has explained what that means, you are not overreacting and you are not imagining the confusion. A positive ANA is one of the most commonly misread results in all of medicine, because the test is deliberately built to be oversensitive. And if it has taken you years and several doctors to get this far, that is not your fault either: in one 2025 study of people with lupus, the average time from the first symptom to the diagnosis was between six and eight and a half years, and it has not shortened in three decades (9).

Note: this article explains what guidelines and research say about testing, and it is not medical advice; a rheumatologist diagnoses lupus, using your history, your exam and your labs together. Call 911 for chest pain, trouble breathing, a seizure, fainting, sudden weakness or numbness on one side, trouble speaking, or the worst headache of your life. Get same-day medical care for a fever you cannot explain, new swelling in your legs, face or around your eyes, foamy or bloody urine, a painful swollen leg, coughing up blood, or new confusion (10, 3).

The lupus workup at a glance

Most lupus workups move through the same four layers, in this order.

The CDC puts the core problem plainly: lupus "can be hard to diagnose since its symptoms are often mistaken for symptoms of other diseases," there is no single test for it, and a rheumatologist is the specialist who usually makes the call (CDC, page last reviewed May 15, 2024) (3). NIAMS says the same thing in one sentence: "At this time, no single test diagnoses lupus" (2).

What does a positive ANA mean?

A positive ANA means your blood contains antibodies that stick to parts of your own cell nuclei — and on its own, it means very little. The test is a screen, not a diagnosis. The US National Library of Medicine's MedlinePlus page (updated March 19, 2025) lists lupus, rheumatoid arthritis, scleroderma, Sjögren's, autoimmune hepatitis and thyroid disease as possible causes, along with viral infections, some cancers, certain medicines, and simply being a healthy older adult (12).

How common is a positive ANA in people without lupus? Common enough to be unremarkable. In a national US survey sample of 4,754 people aged 12 and over, 13.8% were ANA-positive — about 32 million Americans — rising with age and reaching 17.8% in females versus 9.6% in males (7). A later analysis of 13,519 people across three survey periods found the figure climbing over 25 years: 11.0% in 1988–1991, 11.4% in 1999–2004, and 16.1% in 2011–2012, or roughly 41.5 million people (6).

Now hold that next to the number of people who actually have systemic lupus. Using the CDC's national lupus registries, researchers estimated a US prevalence of 72.8 cases per 100,000 people, or about 204,295 Americans (8). Put the two figures side by side — tens of millions ANA-positive, about two hundred thousand with lupus — and the arithmetic is blunt: well under one in a hundred people with a positive ANA has systemic lupus. (These are separate studies of different years and age ranges, so treat this as an order of magnitude, not a precise risk.)

That is the single most useful thing to know walking into your next appointment. A positive ANA is a reason to look further. It is not a diagnosis, and a lab result slip that says "positive" is not a verdict.

What the titer means

The titer — 1:40, 1:80, 1:160, 1:320, 1:640 — is how far your blood can be diluted and still show the antibodies. Higher numbers mean more antibody, and higher numbers are somewhat more likely to matter. The 2019 ACR/EULAR criteria set the bar at a titer of at least 1:80 on HEp-2 cells, or an equivalent positive result on another method (1).

That threshold was not arbitrary. A systematic review and meta-regression of 64 studies covering 13,080 people with lupus, done for the criteria committee and published in January 2018, found that an ANA at 1:80 picked up 97.8% of people with lupus (95% CI 96.8–98.5%), while moving the cutoff to 1:160 dropped that to 95.8% (5). The committee chose the more forgiving cutoff on purpose: they would rather let some healthy people through the door than miss people with lupus.

What the pattern means

Your report may also name a staining pattern: homogeneous, speckled, nucleolar, centromere, cytoplasmic. Patterns are a hint about which specific antibody is present and therefore which disease to think about — a centromere pattern leans toward limited scleroderma, for example. In the national survey of ANA-positive Americans, 84.6% had nuclear patterns, 21.8% cytoplasmic and 6.1% nucleolar, and the most common identifiable specific antibodies were anti-Ro (3.9%) and anti-Su (2.4%) (7). A pattern is a signpost for the next test. It is not a diagnosis either.

Does a positive ANA mean lupus?

No — not by itself, and usually not at all. Interpreting an ANA depends almost entirely on why it was ordered. MedlinePlus notes that providers typically order the test when someone has fever, rash, fatigue, joint or muscle pain, swollen glands or abdominal pain (12). If you have four of those and a rash across your cheeks and nose, a positive ANA is meaningful. If it was drawn as part of a general panel while you felt fine, it usually is not.

This asymmetry is worth saying out loud, because it is the thing that generates years of anxiety: the ANA is a good test for making lupus unlikely and a poor test for making it likely. StatPearls puts its specificity at only about 20% (10).

Which blood tests come after a positive ANA?

After a positive ANA, the follow-up blood work splits into antibodies that are specific to lupus, proteins that drop when lupus is active, and plain organ checks. NIAMS lists the usual second round: antiphospholipid antibodies, anti-Smith and anti-double-stranded DNA antibodies, a complete blood count and a metabolic panel for kidney function, plus a urine test for protein (2).

This is what people mean by a "lupus panel" or "lupus blood test." There is no test by that name; it is a bundle, and different labs bundle it differently.

Anti-dsDNA (anti-double-stranded DNA)

Anti-dsDNA is the closest thing to a lupus-specific blood test, and it is still not a yes-or-no answer. Its specificity is above 95%, but it is present in only about 40% to 80% of people with lupus, so a negative result does not rule lupus out (10). In the 2019 criteria, anti-dsDNA is worth 6 points (1). High levels are also associated with kidney involvement and with disease activity, which is why this test often gets repeated for years after diagnosis.

Anti-Sm (anti-Smith)

Anti-Sm is the most specific antibody of the set and the least sensitive: specificity around 99%, but it shows up in only 10% to 55% of people with lupus (10). If it is positive, it carries real weight. If it is negative, it tells you almost nothing. It also scores 6 points in the 2019 criteria, in the same domain as anti-dsDNA — and because only the highest-scoring item in each domain counts, having both does not give you 12 (1, 14).

Complement C3 and C4

Complement proteins are part of your immune system's plumbing, and in active lupus they get used up faster than your body makes them — so the blood levels fall. That is why a C3 and C4 that are both low is a meaningful finding, and why a rheumatologist may order them repeatedly: StatPearls recommends checking both, noting that low levels indicate complement consumption and may track with disease activity (10). The Lupus Foundation of America (page medically reviewed November 4, 2024) groups complement with CRP as markers that "can signal inflammation somewhere in the body" (4).

In the 2019 criteria, a low C3 or a low C4 scores 3 points; a low C3 and a low C4 scores 4 (1). One caveat worth knowing: a small number of people are born with genetically low C4, so a single low reading means less than a level that falls as you get sicker and rises as you get better.

Antiphospholipid antibodies

This group — anticardiolipin, anti-β2 glycoprotein 1 and the lupus anticoagulant — is tested because it changes risk, not just classification. These antibodies are linked to blood clots and to pregnancy complications, and they score 2 points in the criteria (1). Despite the name, a "lupus anticoagulant" makes clotting more likely, not less, which is one of the more unhelpful names in medicine.

Anti-Ro/SSA, anti-La/SSB and anti-RNP

These do not score points in the 2019 criteria, but they are usually on the same requisition. They help sort lupus from Sjögren's disease and mixed connective tissue disease, and anti-Ro/SSA matters specifically in pregnancy because it is linked to neonatal lupus and congenital heart block. Anti-Ro is also the single most common identifiable specific antibody in ANA-positive people in the general population (7).

Blood counts, kidney tests and urine

These are the quiet ones, and often the most important. Lupus can lower red cells, white cells and platelets, and a complete blood count catches that; a metabolic panel looks for changes in kidney function; a urine test looks for protein and for cell casts that healthy kidneys filter out (2, 4).

Kidney involvement in lupus is often silent at first, which is why the American College of Rheumatology's November 18, 2024 lupus nephritis guideline summary strongly recommends screening for protein in the urine at least every 6 to 12 months in people with lupus who have no known kidney disease, and also when they have a flare outside the kidneys. The same guideline conditionally recommends a kidney biopsy when urine protein is above 0.5 g/g or kidney function is impaired without another explanation (13).

ESR and CRP may also appear on your results. They measure inflammation in general and are not specific to lupus; they are used to follow how you are doing rather than to make the diagnosis (4).

The lupus criteria: how a rheumatologist adds it up

The 2019 EULAR/ACR classification criteria are the scoring system most clinicians have in their heads. They were published in September 2019 and jointly approved by the European Alliance of Associations for Rheumatology and the American College of Rheumatology (1, 16).

They work in three steps.

Step 1 — the entry criterion. You must have had a positive ANA at least once, at a titer of 1:80 or higher on HEp-2 cells, or an equivalent positive test. Without that, the scoring never starts (1).

Step 2 — score the items. Ten domains, each with weighted items. Only the highest-scoring item in a domain counts. An item counts only if there is no more likely explanation for it, and the items do not all have to be present at the same time — something from five years ago still counts.

Step 3 — the threshold. A total of 10 or more points, with at least one clinical (non-laboratory) criterion, classifies the disease as systemic lupus erythematosus. In validation, this performed at 96.1% sensitivity and 93.4% specificity (1).

Two things that surprise people. Joint involvement alone is 6 points, so sore, swollen joints plus a positive anti-dsDNA already hits the threshold. And a kidney biopsy showing class III or IV lupus nephritis scores a full 10 on its own — with a positive ANA, that is enough.

Classification is not the same as diagnosis

This matters, and almost nobody explains it. These are classification criteria. They were built to decide who gets enrolled in research studies, so that a trial in Boston and a trial in Barcelona are studying the same disease. The authors say explicitly that the criteria "are not meant for diagnosis or treatment decisions, and should not be used to exclude patients from therapy" (1).

In the clinic, a rheumatologist can diagnose and treat lupus in someone who scores 8. They can also decline to diagnose lupus in someone who scores 12 because the picture fits something else better. The score is a shared language, not a gate.

Can you have lupus with a negative ANA?

It is possible but unusual, and a negative ANA is the strongest single piece of evidence against lupus that a blood test can give you. At the 1:80 cutoff, the ANA catches 97.8% of people with lupus, which leaves roughly two in a hundred (5). StatPearls puts ANA positivity in lupus at over 97% and says a negative result makes lupus highly unlikely (10). The Lupus Foundation of America gives the same figure from the patient side: "97% of people with lupus will test positive for ANA" (4).

The 2019 criteria make the ANA an obligatory entry point precisely because of this (1). A few situations complicate it:

• Method matters. The criteria specify HEp-2 immunofluorescence or an equivalent test (1). Some labs screen with an automated solid-phase assay first, and a small number of ANA patterns are missed that way. If your symptoms strongly suggest lupus and the ANA is negative, it is reasonable to ask which method the lab used.

• Cutaneous lupus is a different question. Skin-limited forms such as discoid lupus can occur without systemic disease and without a positive ANA, and the CDC's prevalence estimate of 204,295 Americans explicitly excludes cutaneous-only lupus (8).

• Treatment can change the result. People already on immune-suppressing medicines can turn ANA-negative over time.

What a negative ANA usually means, though, is that the answer is somewhere else — and "somewhere else" can be a real, treatable condition. If you are at the stage of chasing a diagnosis for widespread pain and exhaustion, our guide to how fibromyalgia is tested for covers a path that overlaps heavily with this one.

Why does it take so long to get diagnosed?

Because lupus arrives one symptom at a time, in a body that otherwise looks fine on routine tests — and because each symptom, taken alone, has a more boring explanation. A 2025 qualitative study of 268 people with lupus and 25 in-depth interviews found mean times from first symptom to diagnosis of 6 years 8 months for those diagnosed before 1991, 6 years 10 months for 1991–2000, 8 years 6 months for 2001–2010 and 7 years 4 months for 2011–2018, with individual journeys ranging from one month to 40 years (9). The authors found no meaningful improvement across those decades.

The mechanics of the delay are worth naming, because recognizing them makes them easier to interrupt:

• Symptoms don't show up together. The 2019 criteria explicitly allow items to be counted even if they never occurred at the same time (1). Your body is scoring points across years. Nobody is adding them up unless somebody writes them down.

• Fatigue gets absorbed. It is the most common lupus symptom and the one most readily attributed to stress, parenting, work or depression. We wrote about what that exhaustion actually feels like and how people describe it in lupus fatigue.

• The rash is not always the rash. Only a minority of people get a textbook butterfly rash, and when it does appear, it can be mistaken for rosacea or sunburn.

• Symptoms come and go. By the time you get an appointment, the swollen joints have settled. Photographs with dates are genuinely useful evidence.

• Who it affects shapes who gets believed. Lupus is nine times more common in women than men, and prevalence is highest among Black women, then Hispanic, white and Asian/Pacific Islander women, with the highest rates of all in American Indian/Alaska Native people (8). These are also the groups whose symptom reports are most often discounted.

If the open question in your head right now is the frightening one, we answered it separately and carefully in can lupus kill you. The short version is that modern outcomes are far better than the reputation, and that early diagnosis is a large part of why.

What the appointment itself looks like

Nothing about the process is dramatic. Knowing the sequence helps mostly because it tells you when to push.

1. Primary care. Symptoms get described, basic labs get ordered, often including an ANA. This is also where the pattern most often gets split across several visits and never assembled.

2. The ANA result. Positive at 1:80 or higher, and you move on. Negative, and lupus becomes unlikely — ask what else is being considered.

3. Referral to rheumatology. A rheumatologist is the specialist who diagnoses and manages lupus (3, 2). Waits of several months are common in the US; ask to be put on a cancellation list.

4. The second round of labs. Anti-dsDNA, anti-Sm, complement C3 and C4, antiphospholipid antibodies, CBC, metabolic panel, urinalysis with protein-to-creatinine ratio (2).

5. Biopsy, sometimes. A skin biopsy for an unclear rash, or a kidney biopsy if urine protein is above 0.5 g/g or kidney function is unexplained (2, 13).

6. A verdict, or a holding pattern. "Undifferentiated connective tissue disease" and "we'll recheck in six months" are common and legitimate outcomes. They are not a brush-off; some people's disease only declares itself over time.

Treatment is a separate subject and belongs with your rheumatologist; EULAR's 2023 update sets out how lupus is managed and monitored once diagnosed (15).

What else looks like lupus

A positive ANA plus fatigue plus aching joints fits a long list of conditions. These are the ones a rheumatologist is actively sorting between.

• Healthy ANA positivity — No organ involvement, normal counts, normal complement, normal urine; up to 16.1% of the US population is ANA-positive (6)

• Rheumatoid arthritis — Joint erosion on imaging, anti-CCP antibodies, a different joint pattern; see the stages of rheumatoid arthritis

• Sjögren's disease — Dry eyes and dry mouth dominate; anti-Ro/SSA and anti-La/SSB

• Mixed connective tissue disease — Very high anti-RNP with features of several diseases at once

• Fibromyalgia — Widespread pain and unrefreshing sleep with normal inflammatory labs (link)

• Thyroid disease — Thyroid antibodies, abnormal TSH; a frequent cause of a positive ANA (12)

• Viral infection — ANA positivity that is usually short-term (12)

• Drug-induced lupus — Starts after a specific medicine; see below

Drug-induced lupus

Some medicines produce a lupus-like illness that goes away when the drug stops — which makes a medication list part of the diagnostic workup. Procainamide and hydralazine carry the highest documented risk; isoniazid, minocycline and quinidine are well established, and anti-TNF biologics account for a large share of recent reports (11).

What distinguishes it: the course is usually milder, with joint pain, fever, muscle aches, fatigue and inflammation of the lung or heart lining; kidney, brain and blood-vessel involvement are uncommon. Anti-histone antibodies are present in more than 95% of cases caused by hydralazine, procainamide, quinidine or chlorpromazine — though they also appear in up to 80% of ordinary lupus, so they are supporting evidence, not proof. Anti-dsDNA is usually absent. Symptoms typically begin weeks to months after starting the drug, with a median latency around six months, and usually resolve within weeks to months after stopping it, even though the ANA can stay positive for years (11). Symptoms that persist after the drug is withdrawn point back toward lupus itself. Never stop a prescribed medicine on your own; this is a conversation with the prescriber.

Living with an unfinished diagnosis: the questions people ask next

My ANA is positive but my rheumatologist says it isn't lupus. Should I get a second opinion?

Not automatically. A positive ANA with normal complement, normal blood counts, normal urine and no organ findings is the most common result in the world of ANA testing, given that up to 16.1% of the US population tests positive (6). What is reasonable to ask for is a plan: which symptoms would bring you back, and when the labs get rechecked. If new criteria-level findings appear — a seizure, pleuritic chest pain, protein in your urine, a drop in platelets — that is a different conversation.

How often should I be retested?

There is no single answer for people without a diagnosis; your rheumatologist sets the interval. For people who do have lupus, the ACR's November 2024 guideline recommends screening the urine for protein at least every 6 to 12 months even with no known kidney disease, and at any flare outside the kidneys (13).

Does a higher ANA titer mean worse disease?

No. The titer reflects how much antibody is present, not how sick you are or will be. Once you are above the 1:80 entry threshold, the criteria do not award more points for 1:1280 than for 1:80 (1). Disease activity is followed with complement, anti-dsDNA, blood counts and urine — not with repeat ANA titers.

Should I pay for a direct-to-consumer ANA test?

It rarely helps and often hurts. The ANA's value depends almost entirely on the symptoms that prompted it; ordered without that context, a positive result is far more likely to be a false alarm than a finding, given the base rates above (7, 8). If you have symptoms worth testing for, they are worth describing to a clinician who can act on the result.

I'm exhausted and nobody can tell me why yet. How do I plan a week around that?

Pacing is the practical answer most people land on while waiting. Spoon theory is the language a lot of people with lupus use to budget energy across a day, and it works whether or not your diagnosis is settled. If your energy swings in a pattern you can feel but not describe, our piece on what a lupus flare is covers how people recognize their own early warning signs.

What should I write down between now and my appointment?

Dates and specifics beat adjectives. Which joints, on which days, swollen or just sore; mouth ulcers with the date they appeared and healed; hair coming out; a rash and whether sun made it worse; fevers with actual numbers; foamy urine or new swelling in ankles or around the eyes; every medicine and supplement with start dates. A dated list is the single most useful thing you can bring, because the criteria count items that happened at different times (1).

How to bring this up with your doctor

Lead with the pattern, not the worry. "Over the past 14 months I've had three rounds of swollen finger joints lasting about two weeks each, mouth ulcers roughly monthly, hair thinning since March, and a rash on my cheeks that flares after sun. I've also had two low-grade fevers with no infection." That paragraph is worth more than the word "lupus," because it maps directly onto how the criteria are scored (1).

Ask the questions that move things forward.

• "Has my ANA been checked, and if so, what was the titer and the pattern?"

• "Which method did the lab use — HEp-2 immunofluorescence, or a solid-phase assay?"

• "Given these symptoms, should we run anti-dsDNA, anti-Sm, complement C3 and C4, and antiphospholipid antibodies?"

• "Can we check a urine protein-to-creatinine ratio?"

• "If this isn't lupus, what are we ruling in or out instead, and by when?"

• "Does this warrant a rheumatology referral now, or what would need to change for it to?"

Bring materials. Dated photographs of rashes, swollen joints and mouth ulcers. Your symptom list with dates. Copies of old lab results, including any from other health systems. A list of every medicine and supplement with start dates, which is what lets a clinician consider drug-induced lupus (11).

Say what you need. "I'd like a plan with a timeline" is a reasonable sentence to say out loud. So is "I'd like this documented in my chart as an unresolved problem."

The red flags, which override all of the above. Call 911 for chest pain, trouble breathing, a seizure, fainting, sudden weakness or numbness on one side, trouble speaking, or the worst headache of your life. Get same-day medical care for a fever you cannot explain, new swelling in your legs, face or around your eyes, foamy or bloody urine, a painful swollen leg, coughing up blood, or new confusion (10, 3).

Start understanding your body

Learn what affects your energy, stress, sleep, and daily state. Get the app.

Explore your data

How Welltory helps — and what it cannot do

The limits first, because they are the whole frame. Welltory is a general wellness product, not a medical device. It does not diagnose, detect, predict, monitor, prevent, treat or mitigate any condition, including lupus. It cannot tell you whether your ANA means anything, cannot detect a flare, cannot replace a single blood test, and cannot shorten a referral wait. Welltory's own help documentation also states that measurements "may not be accurate if you're under 18 or pregnant," because the algorithm is less reliable in those cases (17).

What it can do is keep a dated record, which is exactly what the diagnostic process runs on. The criteria count symptoms that occurred at different times, months or years apart (1), and the average journey to a lupus diagnosis is measured in years (9). Memory does not survive that. A file does.

The app records the same handful of things the same way every day: resting heart rate, heart rate variability, stress minutes, Battery and sleep. Nothing on that list is a lupus test. What they are is a consistent baseline of your own days, which is the only comparison that means anything — your numbers next to your own history, not next to a line marked normal.

You add the events. Tags go in from the plus sign at the top of the feed: "joints swollen, both hands," "mouth ulcer day 3," "rash after an hour outside," "ANA result 1:320," "rheum appointment." A tag with a date is a data point you will still have in eight months.

My Patterns shows what your tagged events have in common. My Patterns collects tags from your stress and rest stretches on iOS with an Apple Watch or Oura, and patterns start to appear at around seven tagged events in a month. If you tag three times, you will not get a pattern. If you tag a difficult autumn, you may.

The Journal keeps it, and the web app exports it. Journal is a Premium feature that holds your measurements, tags and notes; from the web app you can export a CSV (Dashboard → choose a chart → Export). Walking into a rheumatology appointment with a dated list of symptoms and events — printed, not remembered — is a practical advantage in a process where the whole difficulty is that nobody saw the pattern.

And the honest caveat about patterns. Anything the app shows you is an association, not a cause. "My worst fatigue days cluster after sun exposure" is a hypothesis to hand to your rheumatologist, not a finding. We did not build a Welltory data chart for this article: we do not collect our users' diagnoses, so there is no lupus cohort in our data and no honest chart to draw.

The same red flags apply here, in the same words. Call 911 for chest pain, trouble breathing, a seizure, fainting, sudden weakness or numbness on one side, trouble speaking, or the worst headache of your life. Get same-day medical care for a fever you cannot explain, new swelling in your legs, face or around your eyes, foamy or bloody urine, a painful swollen leg, coughing up blood, or new confusion (10, 3). No app output changes that, whatever your numbers look like.

How we made it

Made with AI tools, then edited and fact-checked by the Welltory team. See our Editorial & AI policy.

No Welltory data chart accompanies this article. Welltory does not collect users' medical diagnoses, so there is no lupus cohort in our data and no honest chart to draw for this topic; the Welltory section describes only what the app records and what it cannot do.

Jane Smorodnikova, co-founder of Welltory, built the methodology behind how we read physiological data.

Written by Tatsiana Yashyna.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data